DGX

Quest Diagnostics Inc

233.01

Jul 31 • 3:59 PM ET -1.29 (-0.55%)

233.01

Aftermarket • 5:00 PM ET 0.00 (0.00%)

Healthcare Diagnostics & Research USA Large NYSE

Peers: LH NTRA A DHR IDXX TMO IQV ICLR WAT MTD

| Held by: VTI VOO VO IVV SPY VTV RSP XLV VOE VIG

Scroll to Statements

Index	S&P 500
Market Cap	25.72B
Enterprise Value	31.86B
Income	1.06B
Sales	11.56B
Book/sh	68.33
Cash/sh	5.67
Dividend Est.	3.33 (1.43%)
Dividend TTM	3.32 (1.42%)
Dividend Ex-Date	Jul 08, 2026
Dividend Gr. 3/5Y	6.62% 7.39%
Payout	36.60%
Employees	57000
IPO	Dec 17, 1996

P/E	24.72
Forward P/E	19.32
PEG	1.94
P/S	2.22
P/B	3.41
P/C	41.08
P/FCF	19.06
EV/EBITDA	14.08
EV/Sales	2.76
Quick Ratio	1.46
Current Ratio	1.59
Debt/Eq	0.85
LT Debt/Eq	0.82
Option/Short	Yes / Yes

EPS (ttm)	9.43
EPS next Y	12.06
EPS next Q	2.87
EPS this Y	13.62%
EPS next Y	7.74%
EPS next 5Y	9.96%
EPS past 3/5Y	3.08% -3.64%
Sales past 3/5Y	3.74% 3.18%
EPS Y/Y TTM	12.51%
Sales Y/Y TTM	9.87%
EPS Q/Q	14.54%
Sales Q/Q	10.21%
Earnings	Jul 23 BMO
EPS/Sales Surpr.	10.53% 2.36%

Insider Own	0.49%
Insider Trans	-13.10%
Inst Own	96.13%
Inst Trans	-1.76%
ROA	6.43%
ROE	14.35%
ROIC	7.72%
Gross Margin	31.87%
Oper. Margin	14.56%
Profit Margin	9.15%
SMA20	7.50%
SMA50	12.61%
SMA200	20.08%
Trades

Shs Outstand	110.00M
Shs Float	109.84M
Short Float	3.20%
Short Ratio	3.78
Short Interest	3.51M
52W High	240.13 -2.97%
52W Low	166.76 39.73%
Volatility	2.42% 2.79%
ATR (14)	6.59
RSI (14)	71.48
Beta	0.55
Rel Volume	0.94
Avg Volume	929.64K
Volume	872,965

Perf Week	2.26%
Perf Month	7.87%
Perf Quarter	19.98%
Perf Half Y	27.78%
Perf YTD	34.28%
Perf Year	39.19%
Perf 3Y	72.33%
Perf 5Y	64.32%
Perf 10Y	169.81%
Recom	2.20
Target Price	248.86
Prev Close	234.30
Price	233.01
Change	-0.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-30-26	Upgrade	Barclays	Equal Weight → Overweight	$210
Aug-25-25	Downgrade	Robert W. Baird	Outperform → Neutral	$194
Apr-02-25	Initiated	Redburn Atlantic	Buy	$195
Mar-04-25	Downgrade	Citigroup	Buy → Neutral	$185
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform	$169 → $174
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142

Show Previous Ratings

Jul-30-26 05:38PM	Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy? (Trefis)
08:26AM	Labcorp raises annual profit forecast on strong testing demand (Reuters)
07:30AM	Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics (PR Newswire)
Jul-27-26 04:56PM	Equinix Stock Has A Message For Management (Trefis)
Jul-23-26 08:30PM	Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary (Moby) +8.61%
05:03PM	Loading…
05:03PM	Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
04:30PM	Quest Diagnostics Inc. stock outperforms competitors on strong trading day (MarketWatch)
10:10AM	Quest Diagnostics Surges After Hims- And Oura-Tied Beat (Investor's Business Daily)
06:52AM	Quest Diagnostics: Q2 Earnings Snapshot (Associated Press)
06:45AM	Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 (PR Newswire)
Jul-10-26 09:24AM	One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns (PR Newswire)
09:00AM	More U.S. Workers Are Testing Positive for Marijuana. Fewer Employers Are Concerned. (The Wall Street Journal)
Jul-08-26 08:52AM	Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI (PR Newswire)
Jun-24-26 08:52AM	Quest Diagnostics Receives New York State Approval for Haystack MRD, Broadening Patient Access to ctDNA Minimal Residual Disease Testing (PR Newswire)
Jun-18-26 08:57AM	UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics (PR Newswire)
09:00AM	Loading…
Jun-17-26 09:00AM	Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 (PR Newswire)
Jun-16-26 09:00AM	Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report (PR Newswire)
May-29-26 07:19AM	The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy? (MarketWatch)
May-19-26 04:37PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
May-14-26 02:22PM	Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch (Barrons.com)
07:21AM	Oracle adds Cleveland Clinic CEO to board of directors (Healthcare Dive)
06:00AM	Labcorp expands Epic pact to make full test menu available on Aura (MedTech Dive)
Apr-30-26 12:30AM	2 Things Matter Most in Picking Winning Stocks, Says This Market Pro (Barrons.com)
Apr-27-26 04:10PM	Quest Diagnostics Prices $500 Million of Senior Notes (PR Newswire)
Apr-23-26 12:33PM	SkylineDx Presents Gene Expression Profiling for Skin Cancer Metastases (Exec Edge)
Apr-22-26 03:01AM	Quest Diagnostics Inc (DGX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
Apr-21-26 12:46PM	Quest Diagnostics Incorporated Q1 2026 Earnings Call Summary (Moby)
09:29AM	The Most Impressive Part Of Quest Diagnostics Stock-Spiking First-Quarter Report (Investor's Business Daily)
06:59AM	Quest Diagnostics: Q1 Earnings Snapshot (Associated Press)
06:47AM	Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 (PR Newswire)
08:57AM	Loading…
Apr-20-26 08:57AM	Digi Power X signs $19.6M GPU rental agreement with SubQ AI (Proactive)
Apr-16-26 09:00AM	City of Hope to Evaluate Quest Diagnostics' Haystack MRD for Guiding Patient Management in Multiple Cancers (PR Newswire)
Apr-10-26 04:43AM	Digi Power X amends equity sales program (Proactive)
Apr-01-26 10:10AM	Digi Power X advances AI infrastructure strategy during 2025 (Proactive)
Mar-19-26 10:00AM	Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026 (PR Newswire)
Mar-12-26 04:07PM	Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors (PR Newswire)
Mar-10-26 08:24AM	Should You Continue to Hold DGX Stock in Your Portfolio? (Zacks)
Mar-05-26 02:53PM	Implied Volatility Surging for Quest Diagnostics Stock Options (Zacks)
Mar-03-26 08:10PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
Mar-02-26 09:02AM	Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results (PR Newswire)
Feb-26-26 09:50AM	Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term (Zacks)
08:24AM	Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer (PR Newswire)
Feb-25-26 10:00AM	Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference (PR Newswire)
Feb-24-26 11:31PM	Labcorp expands PathAI pact to roll out digital pathology platform in US (MedTech Dive)
09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Feb-18-26 06:38AM	Do Wall Street Analysts Like Quest Diagnostics Stock? (Barchart)
Feb-17-26 12:32AM	5 Insightful Analyst Questions From Quest's Q4 Earnings Call (StockStory)
Feb-11-26 09:15AM	Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
12:32AM	DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds (StockStory)
Feb-10-26 10:07PM	Quest Diagnostics Q4 Earnings Call Highlights (MarketBeat) +7.37%
05:45PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
05:08PM	Quest Diagnostics CEO: Chronic Care Disease Management a Big Driver (Bloomberg)
04:02PM	Quest Diagnostics Inc (DGX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
03:30PM	Why Is Quest (DGX) Stock Soaring Today (StockStory)
02:54PM	Stock Market Today: Dow Weakens After Hitting A High; Medical Name Breaks Out (Live Coverage) (Investor's Business Daily)
02:05PM	Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike (Benzinga)
10:43AM	Quest Diagnostics' Q4 Earnings & Revenues Beat Estimates, Stock Up (Zacks)
09:50AM	Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock (Zacks)
07:55AM	Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:13AM	Quest Diagnostics Guides FY26 Above Estimates; Boosts Dividend 7.5% - Update (RTT News)
07:06AM	Quest Diagnostics: Q4 Earnings Snapshot (Associated Press Finance)
06:58AM	Quest's (NYSE:DGX) Q4 CY2025: Beats On Revenue (StockStory)
06:47AM	Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share (PR Newswire)
06:33AM	Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization (PR Newswire)
Feb-09-26 02:08PM	MedTech Stocks to Report Earnings on Feb. 10: DGX, ZBH & EW (Zacks)
Feb-08-26 10:04PM	Quest (DGX) Q4 Earnings: What To Expect (StockStory)
Feb-06-26 09:45AM	Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term (Zacks)
09:45AM	Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings (Zacks)
Feb-05-26 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Feb-04-26 09:40AM	Is Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-03-26 10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
Feb-02-26 08:52AM	Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease (PR Newswire)
Jan-30-26 09:54AM	Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
Jan-26-26 09:40AM	How TEM Is Capitalizing on AI-Driven Pathology Market Growth (Zacks)
Jan-21-26 02:35PM	Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year (PR Newswire)
Jan-15-26 11:15PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
09:00AM	Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect (PR Newswire)
Jan-13-26 11:06PM	3 Reasons to Sell DGX and 1 Stock to Buy Instead (StockStory)
Jan-12-26 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Jan-09-26 02:24PM	Clinical Labs Hope to Head Off Looming Medicare Cuts (Barrons.com)
09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
10:00AM	Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026 (PR Newswire)
08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Is This the Right Time to Add Resmed Stock to Your Portfolio? (Zacks)
Jan-07-26 09:45AM	Quest Diagnostics (DGX) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
07:35AM	Here's Why You Should Add NVST Stock to Your Portfolio Right Now (Zacks)
07:25AM	IDEXX Stock Up 64.7% in a Year: What's Driving the Growth? (Zacks)
Jan-06-26 10:01AM	Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium (PR Newswire)
08:17AM	Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? (Zacks)
08:12AM	Should Labcorp Stock Stay in Your Portfolio Right Now? (Zacks)
Jan-05-26 08:58AM	Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan (PR Newswire)
06:51AM	What You Need To Know Ahead of Quest Diagnostics' Earnings Release (Barchart)
Jan-02-26 07:34AM	Is it the Right Time to Add Insulet Stock to Your Portfolio? (Zacks)
Jan-01-26 10:33PM	Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
Dec-30-25 12:00PM	Quest Diagnostics (DGX) Upgraded to Buy: Here's Why (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 09:40AM	Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-19-25 03:20PM	Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.

ChairmanMr. James E. Davis

Executive VP & CFOMr. Sam A. Samad

Senior VP & General CounselMr. Michael E. Prevoznik J.D.

Executive Vice President of Regional BusinessesMs. Catherine T. Doherty

Senior Vice President of Clinical SolutionsMr. Karthik Kuppusamy Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DELANEY MARK E	SVP & Chief Commercial Officer	Jul 28 '26	Sale	235.18	1,600	376,288	10,335	Jul 29 05:04 PM
DELANEY MARK E	Officer	Jul 28 '26	Proposed Sale	235.18	1,600	376,288		Jul 28 09:46 AM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jun 04 '26	Option Exercise	124.22	8,147	1,012,000	21,657	Jun 08 04:32 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Jun 04 '26	Sale	200.00	8,147	1,629,400	13,510	Jun 08 04:32 PM
KUPPUSAMY KARTHIK	Officer	Jun 04 '26	Proposed Sale	200.00	8,147	1,629,400		Jun 04 02:52 PM
Davis J. E.	CEO and President	Jun 01 '26	Sale	194.14	10,000	1,941,400	132,423	Jun 02 06:38 PM
Davis J. E.	Officer	Jun 01 '26	Proposed Sale	194.14	10,000	1,941,360		Jun 01 12:26 PM
Doherty Catherine T.	EVP, Regional Businesses	Mar 05 '26	Sale	206.21	5,558	1,146,115	67,122	Mar 06 04:45 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 05 '26	Sale	206.21	3,878	799,682	37,557	Mar 06 04:44 PM
Plewman Patrick	SVP for Diagnostic Services	Mar 05 '26	Sale	206.21	2,855	588,730	15,198	Mar 06 04:44 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Mar 04 '26	Sale	204.86	2,628	538,372	13,441	Mar 06 04:43 PM
PREVOZNIK MICHAEL E	Officer	Mar 05 '26	Proposed Sale	206.21	3,878	799,682		Mar 05 11:53 AM
Doherty Catherine T.	Officer	Mar 05 '26	Proposed Sale	206.21	5,558	1,146,115		Mar 05 10:55 AM
Plewman Patrick	Officer	Mar 05 '26	Proposed Sale	206.21	2,855	588,730		Mar 05 10:43 AM
Doherty Catherine T.	EVP, Regional Businesses	Mar 03 '26	Sale	207.73	632	131,285	67,122	Mar 04 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Mar 03 '26	Sale	207.73	526	109,266	37,557	Mar 04 04:38 PM
Davis J. E.	CEO and President	Mar 02 '26	Sale	212.52	10,000	2,125,200	117,185	Mar 04 04:38 PM
Plewman Patrick	SVP for Diagnostic Services	Mar 03 '26	Sale	207.73	410	85,169	15,198	Mar 04 04:38 PM
Doherty Catherine T.	Officer	Mar 03 '26	Proposed Sale	207.73	632	131,285		Mar 03 12:53 PM
PREVOZNIK MICHAEL E	Officer	Mar 03 '26	Proposed Sale	207.73	526	109,266		Mar 03 12:12 PM
Plewman Patrick	Officer	Mar 03 '26	Proposed Sale	207.73	410	85,169		Mar 03 11:52 AM
Davis J. E.	Officer	Mar 02 '26	Proposed Sale	212.52	10,000	2,125,200		Mar 02 02:21 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 19 '26	Sale	204.83	958	196,227	15,838	Feb 20 05:13 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 19 '26	Sale	204.83	1,111	227,566	38,371	Feb 20 05:12 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 19 '26	Sale	204.83	1,433	293,521	68,402	Feb 20 05:11 PM
Plewman Patrick	Officer	Feb 19 '26	Proposed Sale	204.83	958	196,227		Feb 19 10:34 AM
Doherty Catherine T.	Officer	Feb 19 '26	Proposed Sale	204.83	1,433	293,521		Feb 19 10:23 AM
PREVOZNIK MICHAEL E	Officer	Feb 19 '26	Proposed Sale	204.83	1,111	227,566		Feb 19 10:19 AM
Doherty Catherine T.	EVP, Regional Businesses	Feb 13 '26	Option Exercise	112.17	26,165	2,934,928	94,233	Feb 17 04:37 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 13 '26	Sale	206.15	26,165	5,393,815	68,068	Feb 17 04:37 PM
Doherty Catherine T.	Officer	Feb 13 '26	Proposed Sale	207.48	26,165	5,428,714		Feb 13 10:42 AM
Plewman Patrick	SVP for Diagnostic Services	Feb 10 '26	Option Exercise	121.81	5,662	689,660	21,043	Feb 12 04:33 PM
Plewman Patrick	SVP for Diagnostic Services	Feb 10 '26	Sale	204.00	5,662	1,155,048	15,381	Feb 12 04:33 PM
Plewman Patrick	Officer	Feb 10 '26	Proposed Sale	204.00	5,662	1,155,048		Feb 10 12:46 PM
Davis J. E.	CEO and President	Nov 25 '25	Option Exercise	95.80	55,093	5,277,634	175,573	Nov 28 04:30 PM
Davis J. E.	CEO and President	Nov 25 '25	Sale	192.22	55,093	10,589,760	120,480	Nov 28 04:30 PM
Gregg Vicky B	Director	Nov 25 '25	Sale	191.76	1,250	239,700	17,037	Nov 28 04:30 PM
Davis J. E.	Officer	Nov 25 '25	Proposed Sale	192.22	55,093	10,589,762		Nov 25 04:24 PM
Gregg Vicky B	Director	Nov 25 '25	Proposed Sale	191.76	1,250	239,700		Nov 25 09:42 AM
DELANEY MARK E	SVP & Chief Commercial Officer	Nov 18 '25	Option Exercise	144.46	7,946	1,147,845	15,476	Nov 20 04:28 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Nov 18 '25	Sale	187.35	7,946	1,488,683	7,530	Nov 20 04:28 PM
DELANEY MARK E	Officer	Nov 18 '25	Proposed Sale	187.35	7,946	1,488,683		Nov 18 11:02 AM
PFEIFFER GARY M	Director	Oct 22 '25	Sale	182.40	1,482	270,317	29,431	Oct 24 06:10 PM
PFEIFFER GARY M	Director	Oct 22 '25	Proposed Sale	182.40	1,482	270,317		Oct 22 02:10 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Option Exercise	103.57	227	23,510	38,344	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 26 '25	Sale	188.13	227	42,706	38,117	Sep 30 04:36 PM
PREVOZNIK MICHAEL E	Officer	Sep 26 '25	Proposed Sale	188.13	227	42,706		Sep 26 04:12 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Option Exercise	103.57	28,288	2,929,788	66,405	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Option Exercise	103.57	175	18,125	38,292	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 23 '25	Sale	187.12	28,288	5,293,313	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Sep 24 '25	Sale	187.02	175	32,729	38,117	Sep 25 04:39 PM
PREVOZNIK MICHAEL E	Officer	Sep 24 '25	Proposed Sale	187.02	175	32,729		Sep 24 04:10 PM
PREVOZNIK MICHAEL E	Officer	Sep 23 '25	Proposed Sale	187.12	28,288	5,293,313		Sep 23 04:14 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 21 '25	Sale	185.00	1,975	365,375	15,269	Aug 25 04:27 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Option Exercise	112.17	4,532	508,354	21,776	Aug 21 04:34 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 19 '25	Sale	183.00	4,532	829,356	17,244	Aug 21 04:34 PM
Plewman Patrick	Officer	Aug 21 '25	Proposed Sale	185.00	1,975	365,375		Aug 21 12:10 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 15 '25	Sale	180.00	1,975	355,500	17,244	Aug 19 04:47 PM
Plewman Patrick	Director	Aug 19 '25	Proposed Sale	183.00	4,532	829,356		Aug 19 04:09 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	72	12,960		Aug 15 05:29 PM
Plewman Patrick	Officer	Aug 15 '25	Proposed Sale	180.00	1,903	342,540		Aug 15 05:22 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Option Exercise	86.63	3,560	308,403	24,745	Aug 08 04:40 PM
Plewman Patrick	SVP for Diagnostic Services	Aug 06 '25	Sale	175.00	5,535	968,625	19,219	Aug 08 04:40 PM
Plewman Patrick	Officer	Aug 06 '25	Proposed Sale	175.00	5,535	968,625		Aug 06 01:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics Inc

Upgrade your Finviz experience